Amwell Raises 2026 Revenue Guidance to $200M–$205M, Narrows EBITDA Loss
AMWL has more than doubled off its 52-week low of $3.71.
Summary
Amwell raised its full-year 2026 revenue guidance to $200–$205 million and narrowed its adjusted EBITDA loss forecast to $(9)–$(7) million, signaling improving cost discipline despite a 27% Q2 revenue decline. The company also granted 6,679 RSUs to two new non-executive hires, vesting over 48 months. This follows the Q2 earnings release on August 4th, adding forward-looking targets that were not previously disclosed. The guidance raise and narrower loss outlook suggest management sees a path to stabilization, though top-line pressure persists.
At the time of this announcement, AMWL was trading at $13.04 on NYSE in the Technology sector, with a market capitalization of approximately $230M. The 52-week trading range was $3.71 to $14.19. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.